Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-03-26

Clinical Trial Update: Study of Berberine Hydrochloride in Prevention of Colorectal Adenomas Recurrence [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial evaluating berberine hydrochloride for prevention of colorectal adenoma recurrence has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Berberine hydrochloride (berberine hydrochloride)

Snippet

Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: Colorectal Adenoma | Phase 2, Phase 3 | Status: COMPLETED